FindTrial
Sign In

Clinical trail for dyspepsia in children

CLINICAL EVALUATION OF SEENTHIL KUDINEER FOR KATTU MANTHAM (DYSPEPSIA) IN CHILDREN.

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/04/006818
Enrollment
40
Registered
2016-04-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Constipation Indigestion Stomach Pain Cough Fever

Interventions

Intervention1: Seenthil Kudineer: Seenthil kudineer 10 ml BD orally for a day only Control Intervention1: Nil: Nil

Sponsors

National Institute of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Indigestion Stomach Pain Cough Fever Constipation

Exclusion criteria

Exclusion criteria: Irritable Bowel syndrome Childhood asthma Intolerable stomach pain

Design outcomes

Primary

MeasureTime frame
Relief from the symptomsTimepoint: 2 days—

Secondary

MeasureTime frame
any toxicity of the drugTimepoint: 14 days—

Countries

India

Contacts

Public ContactDrAAmalaHazel MDs

National Institute of Siddha

mirunalenibsms@gmail.com8122978302

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026